We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 21st:
Amedisys, Inc. (AMED - Free Report) : This provider of healthcare services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
AmerisourceBergen Corporation : This distributor of pharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
Target Corporation (TGT - Free Report) : This general merchandise retailer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.
Westlake Chemical Partners LP (WLKP - Free Report) : This developer and operator of ethylene production facilities and related assets has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for June 21st
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 21st:
Amedisys, Inc. (AMED - Free Report) : This provider of healthcare services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
Amedisys, Inc. Price and Consensus
Amedisys, Inc. price-consensus-chart | Amedisys, Inc. Quote
Amedisys'shares gained 10% over the last one month against the S&P 500’s rise of 3.3%. The company possesses a Momentum Score of B.
Amedisys, Inc. Price
Amedisys, Inc. price | Amedisys, Inc. Quote
AmerisourceBergen Corporation : This distributor of pharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
AmerisourceBergen Corporation Price and Consensus
AmerisourceBergen Corporation price-consensus-chart | AmerisourceBergen Corporation Quote
AmerisourceBergen’s shares gained 5.1% over the last one month. The company possesses a Momentum Score of B.
AmerisourceBergen Corporation Price
AmerisourceBergen Corporation price | AmerisourceBergen Corporation Quote
Target Corporation (TGT - Free Report) : This general merchandise retailer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.
Target Corporation Price and Consensus
Target Corporation price-consensus-chart | Target Corporation Quote
Target’s shares gained 21.4% over the last one month. The company possesses a Momentum Score of A.
Target Corporation Price
Target Corporation price | Target Corporation Quote
Westlake Chemical Partners LP (WLKP - Free Report) : This developer and operator of ethylene production facilities and related assets has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.
Westlake Chemical Partners LP Price and Consensus
Westlake Chemical Partners LP price-consensus-chart | Westlake Chemical Partners LP Quote
Westlake Chemical’s shares gained 6.6% over the last one month. The company possesses a Momentum Score of B.
Westlake Chemical Partners LP Price
Westlake Chemical Partners LP price | Westlake Chemical Partners LP Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>